PRTAHealthcare
Prothena Corporation plc (PRTA) Insider Trading
In the last 90 days, 1 Prothena Corporation plc (PRTA) insider reported 10 open-market purchases totaling $8,977,786 and no sales. The most recent open-market purchase was reported on Oct 23, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $8,977,786
- Corporate buyers
- 1
- Latest transaction
- Oct 23, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
PRTA insider trading FAQ
- Are PRTA insiders buying or selling?
- Over the last 90 days, PRTA insiders were net buyers, reporting $8,977,786 of open-market purchases and $0.00 of sales.
- When was the last PRTA insider purchase?
- The most recent open-market purchase of Prothena Corporation plc stock by an insider was reported on Oct 23, 2026, one of 10 purchases in the last 90 days.
- Where does PRTA insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Prothena Corporation plc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- CSTL insider tradingCastle Biosciences Inc20 filings
- CLOV insider tradingClover Health Investments Corp18 filings
- MEDP insider tradingMedpace Holdings Inc18 filings
